Donald and Barbara Zucker School of Medicine Academic Works - Academic Competition and Research Symposium: The Prognostic Significance of Peripheral Blood Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer Treated with Pembrolizumab: A Clinical Study
 

The Prognostic Significance of Peripheral Blood Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer Treated with Pembrolizumab: A Clinical Study

Facility

Staten Island University Hospital

Department

Department of Medicine

Status

Resident

Category

Clinical Science Research

Start Date

2-6-2021 12:00 AM

This document is currently not available here.

Plum Print visual indicator of research metrics
PlumX Metrics
  • Usage
    • Abstract Views: 7
see details

Share

COinS
 
Jun 2nd, 12:00 AM

The Prognostic Significance of Peripheral Blood Biomarkers in Patients with Advanced Non-Small Cell Lung Cancer Treated with Pembrolizumab: A Clinical Study